Study finds chemo might be unnecessary for some forms of breast cancer

Leslie Hanson
June 8, 2018

She was in Chicago where the groundbreaking Trial Assigning Individualized Options for Treatment or TAILORx study was presented.

"In the right patients, it works very well".

There are several ways you can lower your risk of breast cancer: Get an annual breast screening, for most women this begins at age 40; be physically active and exercise; reduce lifetime weight by making healthy food choices; avoid smoking; limit alcohol intake; and practice meditation, do yoga or find other ways to reduce stress. At five years, the overall survival rate was 98.0 percent for those who received hormone therapy alone and 98.1 percent for those who received both therapies, and at nine years the respective overall survival rates were 93.9 percent and 93.8 percent.

"Chemotherapy is not without its side effects, but it's still a discussion that a woman has to have with her physician", said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital.

"This is a real problem, the joint pain", she told the Press Association.

But some of the more striking developments unveiled in the past week involve breast cancer. Women deemed at intermediate risk may be considered for it, but on a patient-to-patient basis.

Those with a BMI above 30 - around 140 patients - recorded an average "worst pain" score of seven out of 10 before taking the supplement or a placebo.

There was no significant change among non-obese patients. But many women also are urged to have chemo to help kill any stray cancer cells.

The side effect is extremely common among those receiving chemoradiotherapy. And while it doesn't officially wrap up until Tuesday afternoon, the confab's already produced a flurry of news on the latest in cancer drug development, from updates on immune therapy R&D to the promise (and, importantly, the limitations) of newfangled treatments for a growing number of cancers.

At the end of treatment they had less difficulty urinating, while in the next month they experienced less general pain and less discomfort while having sex than those who had not taken the supplement.

Patients who had chemoradiotherapy before surgery lived longer on average.

Carolina's Lineberger Comprehensive Cancer Center, said she'd be quite comfortable counseling patients to bypass chemo if they had been like those from the study who didn't gain from it.

Organizations focused on curing breast cancer say chemotherapy is not a one-size-fits-all treatment anymore.

Between 10 to 15 in 100 patients diagnosed with pancreatic cancer are eligible for surgery.

Dr Alistair Ring, a consultant at the Royal Marsden Hospital in London, thinks that 3,000 women a year in the United Kingdom will not need chemotherapy anymore because of this trial.

Findings of the past have indicated that women who met these criteria and scored below ten on the index test could safely skip chemotherapy without raising their rate of recurrence, however, those above 25 would nearly always be advised to use chemotherapy as a necessary treatment to lower risk of recurrence.

"While these drugs are invaluable in helping to stop the cancer returning, they can make moving forward feel like an uphill struggle". This finding indicates the need to develop more effective therapies for women at high risk of recurrence.

Other reports by Iphone Fresh

Discuss This Article